An analysis of pharmaceutical talent trends has revealed that the industry must address the looming skills shortages or risk losing the best candidates to other sectors.
An analysis of pharmaceutical talent trends has revealed that the industry must address the looming skills shortages or risk losing the best candidates to other sectors.
According to the latest market research from specialist Life Sciences recruiter, Clinical Professionals, there are three key strategies the industry must implement to stay ahead in the talent crisis:
- Smart pipelining and pooling: In an increasingly competitive talent environment, it’s vital to build a pool of talent that matches future demand. Working with your CRO or a Functional Services Provider (FSP) can help develop a pipeline of engaged candidates, but don’t forget to make the most of digital innovations as well.
- Reaching out to new communities: Where talent comes from should not be limited to the usual sources. Businesses in the sector need to look at wider communities that may harbor future pharmaceutical talent. Graduates looking to develop their career as a physician, for example, could be future candidates for the Clinical Research, Medical Affairs and Pharmacovigilance arenas.
- Think global, not local: The talent pipeline is now internationally available and should be utilized, particularly for an industry with limited available skills. Businesses in the sector must be engaging with talent across borders using a strong employer brand message.
Yvette Cleland, Managing Director at Clinical Professionals commented on this potential skills shortage. “The upheaval the industry has noted isn’t surprising given the challenges most organizations have faced, from clinical trials failing to clients demanding more. But while the changing pharma environment and budget constraints can’t always be helped, it’s important that the people element of business isn’t pushed to one side. At the end of the day, it is this talent that really places organisations ahead of the competition.”
“Regardless of the solution organizations opt for, what is vital is that the industry gets talent back at the top of its agenda. Without the highly skilled people to drive innovation and clinical research, the pharmaceutical sector will struggle to progress.” She continued.
For more information visit www.clinicalprofessionals.co.uk
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Vabysmo Shows Significant Vision Improvement for Diabetic Macular Edema in Underrepresented Patients
October 22nd 2024Phase IV ELEVATUM trial results show that one year of treatment with Vabysmo significantly improved vision in underrepresented racial and ethnic groups with diabetic macular edema, supporting the drug's efficacy and safety across diverse populations.